08:30        Registration, Partnering Meetings & Networking in the Exhibition Hall

09:00        Welcome & Introduction
                      Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

09:05        Enabling and Intensifying Manufacturing of Biologics
                      Véronique Chotteau, Professor in Mammalian Cell-Based Bioprocess Technology, KTH Royal Institute of Technology

09:30        In-House Development of a Protein-Based Biological Drug: A Next-Generation Botulinum Neuromodulator Product for the Aesthetic Market
                      Ulf Ståhl, Product Research Leader, Galderma

09:55        Coffee, Partnering Meetings & Networking in the Exhibition Hall

10:30        To Be Announced

10:55        To Be Announced

11:20        Karolinska ATMP Centre: Accelerating Translational Research into Clinical Application
                      Knut Steffensen, Director, Karolinska ATMP Center, Karolinska Institutet

11:45        Lunch, Partnering Meetings & Networking in the Exhibition Hall

12:45        Introducing Cell and Gene Therapies in Sweden – the Role of the New Therapies Council
                      Åsa Derolf, Chair of the New Therapies Council (NT-rådet)

13:10        The Price of Innovation: How Do We Ensure Access to Gene Therapy?
                      – New payment models are needed for life-changing rare disease therapies
                      Fredrik Sjöö, Head of Medical Affairs, Nordic Region, CSL Behring

13:35        Immune Checkpoint Induction by a Topical Oligonucleotide Therapy for Atopic Dermatitis
                      Anna-Lena Spetz, Chief Scientific Officer, TIRmed Pharma

14:00        Coffee, Partnering Meetings & Networking in the Exhibition Hall

14:30        CAR-T Cells – Swedish Experiences
                      Gunilla Enblad, Professor in Oncology, Uppsala University

14:55        Transplantation of Allogeneic Beta Cells with No Immunosuppression
                      Per-Ola Carlsson, Professor in Medical Cell Biology, Uppsala University

15:20        To Be Announced
                      Speaker from Eli Lilly announced shortly

15:45        Summary & Conclusion
                      Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

15:50        End of Agenda